# Morocco Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Morocco HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Morocco (MAR)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $60.1M
- Products: 21
- Buyer markets: 24
- Average CAGR: +4.5%
- Global sector size: $477.5B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $286.9B | $24.3M | $102.0B | +9.9% | 19 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $27.7B | $4.5M | $18.1B | +3.1% | 10 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $33.5B | $26.3K | $14.9B | -3.9% | 4 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $23.1B | $582.0 | $12.3B | -50.8% | 4 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $9.8M | $10.7B | +48.5% | 3 | +0.1% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $14.3B | $1.5K | $9.5B | -13.4% | 4 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $8.3B | $20.1K | $9.1B | -18.6% | 2 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $10.1B | $3.4M | $8.5B | +20.0% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $1.1M | $8.0B | +19.0% | 4 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $7.9B | $37.0K | $6.8B | -2.2% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $10.3K | $4.6B | -5.1% | 3 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $6.6B | $7.3M | $4.0B | +21.0% | 2 | +0.1% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $5.7B | $94.8K | $3.3B | -5.4% | 2 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $781.3K | $1.9B | +40.3% | 1 | +0.1% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $3.6B | $178.1K | $1.8B | +45.2% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $9.8K | $1.4B | -11.9% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $6.6K | $1.4B | +17.6% | 1 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $2.2B | $8.5M | $1.2B | +37.6% | 1 | +0.3% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $4.3 | $1.1B | -15.3% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $2.5 | $1.0B | +12.0% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $58.5 | $981.1M | -1.4% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $44.0B calculated opportunity across 9 products.
- Switzerland, Liechtenstein (CHE): $37.8B calculated opportunity across 5 products.
- Belgium (BEL): $24.0B calculated opportunity across 5 products.
- Germany (DEU): $19.2B calculated opportunity across 7 products.
- Netherlands (NLD): $14.7B calculated opportunity across 4 products.
- China (CHN): $14.1B calculated opportunity across 5 products.
- France (FRA): $10.1B calculated opportunity across 6 products.
- Spain (ESP): $8.9B calculated opportunity across 4 products.
- Canada (CAN): $7.5B calculated opportunity across 4 products.
- United Kingdom (GBR): $7.3B calculated opportunity across 3 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.
- Mexico (MEX): $4.8B calculated opportunity across 2 products.

## Growth stars

- HS 330210: +48.5% average CAGR, $10.7B calculated opportunity.
- HS 310420: +45.2% average CAGR, $1.8B calculated opportunity.
- HS 382319: +40.3% average CAGR, $1.9B calculated opportunity.
- HS 300214: +37.6% average CAGR, $1.2B calculated opportunity.
- HS 330300: +21.0% average CAGR, $4.0B calculated opportunity.
- HS 382600: +20.0% average CAGR, $8.5B calculated opportunity.
- HS 330499: +19.0% average CAGR, $8.0B calculated opportunity.
- HS 340220: +17.6% average CAGR, $1.4B calculated opportunity.
- HS 300290: +12.0% average CAGR, $1.0B calculated opportunity.
- HS 300490: +9.9% average CAGR, $102.0B calculated opportunity.

## Diversification opportunities

- HS 300490: 19 buyer markets, $102.0B calculated opportunity.
- HS 382499: 10 buyer markets, $18.1B calculated opportunity.
- HS 300215: 4 buyer markets, $14.9B calculated opportunity.
- HS 300212: 4 buyer markets, $12.3B calculated opportunity.
- HS 293499: 4 buyer markets, $9.5B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 300439: 4 buyer markets, $6.8B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 382600: 3 buyer markets, $8.5B calculated opportunity.
- HS 382200: 3 buyer markets, $4.6B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.